Profound Medical PROF Income Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $5.34M-10.7% | $5.98M+13.0% | $5.29M+139% | $2.21M-15.6% | $2.62M-37.2% | ||
| $1.51M-24.2% | $1.99M+46.2% | $1.36M+129% | $593K-22.8% | $768K-36.7% | ||
| $3.83M-4.0% | $3.99M+1.5% | $3.93M+143% | $1.62M-12.7% | $1.85M-37.4% | ||
| 71.8%+5.0pp | 66.8%-7.6pp | 74.3%+1.1pp | 73.2%+2.5pp | 70.7%-0.2pp | ||
| $5.26M+23.2% | $4.27M-21.2% | $5.42M-11.2% | $6.1M+26.8% | $4.81M+3.4% | ||
| $6.59M-7.0% | $7.09M-4.6% | $7.43M-20.4% | $9.33M+13.6% | $8.21M+23.3% | ||
| $11.85M+4.3% | $11.36M-11.6% | $12.84M-16.7% | $15.42M+18.5% | $13.02M+15.1% | ||
| $11.85M+4.3% | $11.36M-11.6% | $12.84M-16.7% | $15.42M+18.5% | $13.02M+15.1% | ||
| -$8.02M-8.8% | -$7.37M+17.3% | -$8.91M+35.4% | -$13.81M-23.6% | -$11.17M-33.8% | ||
| -150.3%-27.0pp | -123.3%+45.2pp | -168.5%+456pp | -624.4%-198pp | -426%-226pp | ||
| $377K+136% | $160K+31.1% | $122K-64.4% | $343K-22.9% | $445K+34.0% | ||
| $993K+227% | -$780K-174% | $1.06M+158% | -$1.83M-478% | $483K-84.7% | ||
| -$7.03M+13.8% | -$8.15M-3.7% | -$7.86M+49.7% | -$15.63M-46.3% | -$10.68M-106% | ||
| $25K-3.8% | $26K-78.5% | $121K+89.1% | $64K+56.1% | $41K+117% | ||
| -$7.05M+13.7% | -$8.18M-2.5% | -$7.98M+49.2% | -$15.7M-46.4% | -$10.72M-117% | ||
| -132.2%+4.6pp | -136.8%+14.0pp | -150.8%+559pp | -709.9%-301pp | -409.2%-291pp | ||
| $0.19-29.6% | $0.27+3.8% | $0.26-50.0% | $0.52+44.4% | $0.36+100.0% | ||
| $0.19-29.6% | $0.27+3.8% | $0.26-50.0% | $0.52+44.4% | $0.36+100.0% | ||
| 36.3M+20.1% | 30.2M+0.4% | 30.1M+0.2% | 30.1M0.0% | 30M+21.3% | ||
| 36.3M+20.1% | 30.2M+0.4% | 30.1M+0.2% | 30.1M0.0% | 30M+21.3% | ||
| $377K+136% | $160K+31.1% | $122K-64.4% | $343K-22.9% | $445K+34.0% | ||
| -$8.06M-2.0% | -$7.9M+10.1% | -$8.79M+32.3% | -$12.98M-22.2% | -$10.62M-53.6% | ||
| -$2K-114% | $14K-33.3% | $21K+250% | -$14K— | $0+100% | ||
| $616K+166% | -$940K-201% | $935K+143% | -$2.17M-5,805% | $38K-98.7% | ||
| -$1.01M-465% | $275K+134% | -$808K-130% | $2.71M+2,534% | $103K+105% | ||
| -$8.02M-8.8% | -$7.37M+17.3% | -$8.91M+35.4% | -$13.81M-23.6% | -$11.17M-33.8% | ||
| -$7.92M-9.1% | -$7.26M+17.2% | -$8.77M+35.9% | -$13.67M-24.2% | -$11M-35.7% | ||
| -$7.92M-9.1% | -$7.26M+17.2% | -$8.77M+35.9% | -$13.67M-24.2% | -$11M-35.7% | ||
| -148.4%-27.0pp | -121.5%+44.3pp | -165.7%+452pp | -618%-198pp | -419.8%-226pp | ||
| -$8.02M-8.8% | -$7.37M+17.3% | -$8.91M+35.4% | -$13.81M-23.6% | -$11.17M-33.8% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is Profound Medical's revenue?
- Profound Medical (PROF) generated $18.8M in revenue over the trailing twelve months, up 58.6% year over year.
- Is Profound Medical profitable?
- Profound Medical is not currently profitable: it reported a net loss of $38.9M over the trailing twelve months, a -206.8% net margin.
- What are Profound Medical's profit margins?
- Gross margin is 71.1% and operating margin is -202.6%, with a -206.8% net margin.
- What is Profound Medical's earnings per share?
- Profound Medical's diluted EPS over the trailing twelve months is $1.24.
- Where does Profound Medical's income statement data come from?
- Every line is extracted from Profound Medical's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
